These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30867076)

  • 21. Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression.
    Veen C; Myint AM; Burgerhout KM; Schwarz MJ; Schütze G; Kushner SA; Hoogendijk WJ; Drexhage HA; Bergink V
    J Affect Disord; 2016 Jan; 189():298-305. PubMed ID: 26454336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Goldsmith DR; Rapaport MH; Miller BJ
    Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjects.
    Jospeh MH; Baker HF; Crow TJ; Riley GJ; Risby D
    Psychopharmacology (Berl); 1979 Apr; 62(3):279-85. PubMed ID: 111294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.
    Gevi F; Zolla L; Gabriele S; Persico AM
    Mol Autism; 2016; 7():47. PubMed ID: 27904735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder.
    Maget A; Platzer M; Bengesser SA; Fellendorf FT; Birner A; Queissner R; Hamm C; Reininghaus B; Hecker A; Tomberger L; Pilz R; Dalkner N; Moll N; Schütze G; Schwarz M; Kapfhammer HP; Reininghaus EZ
    Curr Top Med Chem; 2020; 20(15):1344-1352. PubMed ID: 31376822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan Metabolism and White Matter Integrity in Schizophrenia.
    Chiappelli J; Postolache TT; Kochunov P; Rowland LM; Wijtenburg SA; Shukla DK; Tagamets M; Du X; Savransky A; Lowry CA; Can A; Fuchs D; Hong LE
    Neuropsychopharmacology; 2016 Sep; 41(10):2587-95. PubMed ID: 27143602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of the tryptophan metabolome in urine of patients with acute intermittent porphyria.
    Gomez-Gomez A; Marcos J; Aguilera P; To-Figueras J; Pozo OJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():347-354. PubMed ID: 28666226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia.
    Fazio F; Lionetto L; Curto M; Iacovelli L; Cavallari M; Zappulla C; Ulivieri M; Napoletano F; Capi M; Corigliano V; Scaccianoce S; Caruso A; Miele J; De Fusco A; Di Menna L; Comparelli A; De Carolis A; Gradini R; Nisticò R; De Blasi A; Girardi P; Bruno V; Battaglia G; Nicoletti F; Simmaco M
    Sci Rep; 2015 Dec; 5():17799. PubMed ID: 26643205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linking nervous and immune systems in psychiatric illness: A meta-analysis of the kynurenine pathway.
    Sales PMG; Schrage E; Coico R; Pato M
    Brain Res; 2023 Feb; 1800():148190. PubMed ID: 36463958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kynurenines: from the perspective of major psychiatric disorders.
    Myint AM
    FEBS J; 2012 Apr; 279(8):1375-85. PubMed ID: 22404766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia.
    Chiappelli J; Notarangelo FM; Pocivavsek A; Thomas MAR; Rowland LM; Schwarcz R; Hong LE
    Neuropsychopharmacology; 2018 Jul; 43(8):1675-1680. PubMed ID: 29520060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontostriatal circuitry and the tryptophan kynurenine pathway in major psychiatric disorders.
    Liang S; Zhao L; Ni P; Wang Q; Guo W; Xu Y; Cai J; Tao S; Li X; Deng W; Palaniyappan L; Li T
    Psychopharmacology (Berl); 2024 Jan; 241(1):97-107. PubMed ID: 37735237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kynurenine pathway and white matter microstructure in bipolar disorder.
    Poletti S; Myint AM; Schüetze G; Bollettini I; Mazza E; Grillitsch D; Locatelli C; Schwarz M; Colombo C; Benedetti F
    Eur Arch Psychiatry Clin Neurosci; 2018 Mar; 268(2):157-168. PubMed ID: 27619930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolism.
    Gottschalk MG; Wesseling H; Guest PC; Bahn S
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25609598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane Na(+)-K+ ATPase mediated cascade in bipolar mood disorder, major depressive disorder, and schizophrenia--relationship to hemispheric dominance.
    Kurup AR; Kurup PA
    Int J Neurosci; 2002 Aug; 112(8):965-82. PubMed ID: 12448837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Uptake of tryptophan and tyrosine in some cases of manic depressive psychosis and schizophrenia (author's transl)].
    Tissot R; Castellanos G; Gaillard JM; Estrada E; Eisenring JJ; Boleaga B; Hyde A; Miranda R; Hovaguimian T
    Neuropsychobiology; 1978; 4(2):65-73. PubMed ID: 619304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant amino acid transport in fibroblasts from patients with bipolar disorder.
    Persson ML; Johansson J; Vumma R; Raita J; Bjerkenstedt L; Wiesel FA; Venizelos N
    Neurosci Lett; 2009 Jun; 457(1):49-52. PubMed ID: 19429160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kynurenine pathway and neurodegenerative disease.
    Maddison DC; Giorgini F
    Semin Cell Dev Biol; 2015 Apr; 40():134-41. PubMed ID: 25773161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome.
    Yang Z; Cai X; Xu X; Xu Z; Ye S; Wang Y; Hong Y; Shen B; Liao Q; Xie Z; Wang X
    Anal Biochem; 2022 Jun; 647():114665. PubMed ID: 35339450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.